Enlivex Therapeutics Ltd. (ENLV)
NASDAQ·Healthcare·Biotechnology
$2.71
+4.10%
Mkt Cap $2.92M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+453.5%
Consensus $15.00 vs current $2.71
NASDAQ·Healthcare·Biotechnology
$2.71
+4.10%
Mkt Cap $2.92M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+453.5%
Consensus $15.00 vs current $2.71